Suicidality in Fibromyalgia: A Systematic Review of the Literature

Daniella Levine1,2, Danny Horesh3,4

  • 1Department of Psychology, New York University, New York, NY, United States.

Frontiers in Psychiatry
|November 11, 2020
PubMed

Insights

Suicidal ideation and behavior are common in fibromyalgia (FM). Factors like psychiatric issues, sleep problems, and unemployment increase risk. More research is needed to understand and treat suicidality in FM patients.

Area of Science:

  • Rheumatology
  • Psychiatry
  • Public Health

Background:

  • Fibromyalgia (FM) is a poorly understood rheumatic condition causing chronic pain, fatigue, cognitive issues, and psychiatric comorbidities like depression and anxiety.
  • Social stigma surrounds FM due to its unclear etiology and nature, exacerbating patient suffering.
  • While psychological distress is recognized, the prevalence and contributing factors of suicidality in FM patients remain unclear.

Approach:

  • This review systematically summarizes existing data on suicide-related outcomes in FM patients.
  • It identifies factors associated with suicidal ideation and behavior within this population.
  • The review also highlights literature gaps to guide future research and clinical practice.

Key Points:

  • Suicidal ideation and behavior are prevalent among individuals with FM.
  • Psychiatric comorbidity, sleep difficulties, and inpatient hospitalization are linked to both suicidal ideation and behavior.
  • Functional impairment, female gender, unemployment, lower income, medical comorbidity, and drug dependence are associated with increased suicidality in FM.

Conclusions:

  • Understanding risk factors is crucial for improving FM research and clinical care.
  • Methodological and conceptual limitations in current studies were identified.
  • Future research should prioritize longitudinal studies and explore the biological and psychological underpinnings of FM and suicidality.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
626
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
297
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.0K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
367
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.2K